Moolec Science (MLEC) announced that Nasdaq Staff has issued a memorandum to the Nasdaq Hearings Panel concluding that there is sufficient basis to grant Moolec an exception through June 29 to demonstrate compliance with the stockholders’ equity requirement set forth in Nasdaq Listing Rule 5550(b)(1), subject to certain disclosure conditions. The Staff memo reflects Nasdaq’s acknowledgment of the material improvement in Moolec’s balance sheet following a series of accounting and corporate events completed during the fourth quarter of 2025, which the company believes have restored compliance with the Stockholders’ Equity Requirement.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MLEC:
- Moolec Science Wins Nasdaq Extension After Equity Boost from Subsidiary Bankruptcies
- Moolec Science receives Nasdaq panel exception to regain compliance
- Moolec Science Completes 15-for-1 Share Consolidation on Nasdaq
- Upcoming Stock Splits This Week (January 5 to January 9) – Stay Invested
- Moolec Science SA trading halted, news pending
